Clinical Trial Update: Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

View source ↗

Summary

Clinical trial update on biomarkers that may predict response to treatment in newly diagnosed stage III/IV head and neck cancer treated with carboplatin, paclit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Head and Neck Cancer | Status: TERMINATED